MicroRNA表达在宫颈癌及癌前病变中的差异研究

摘要
图/表
参考文献
相关文章 (1)

全文: PDF (2347 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要 目的：探讨宫颈鳞状细胞癌（SCC）和高级别鳞状上皮内病变（HSIL）患者血液中微小RNAs（microRNA,miRNAs）的表达差异。方法：于2020年1月―2022年1月,纳入35名HSIL和35名宫颈SCC患者和30名健康对照进行研究。收集患者的血液标本,采用qRT-PCR分析血清中miR-409、miR-32、miR-454、miR-17、miR-520和miR-373的相对miRNA表达水平。采用接受者操作特征曲线（ROC）分析差异表达的miRNAs的诊断潜力。结果：与健康对照组比较,HSIL和SCC组织中miR-409表达显著下调,miR-32、miR-454、miR-17表达均显著上调。与HSIL组比较,SCC组的miR-409表达显著下调,miR-32、miR-454、miR-17表达均显著上调。ROC分析显示,miR-409（AUC=0.972）、miR-32（AUC=0.942）、miR-454（AUC=0.905）、miR-17（AUC=0.969）在区分对照组和SCC组方面具有高特异度和高敏感度。miR-409（AUC=0.921）、miR-17（AUC=0.851）在区分HSIL组和SCC组方面具有较高的特异度和敏感度。miR-32、miR-454在区分HSIL组和SCC组方面价值较低。结论：宫颈癌及癌前病变中的miRNAs（miR-409、miR-32、miR-454、miR-17）具有明显差异表达,且在区分正常和SCC方面显示出良好的敏感性和特异性。其中,miR-409和miR-17还可作为区分HSIL和SCC的潜在标志物。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	赵文娇
	刘芳
	闫琼琼

关键词 ： microRNA, 宫颈癌, 高级别鳞状上皮内病变

Abstract：Objective To investigate the expression of miRNAs in the blood of patients with squamous cell carcinoma (SCC) and high-grade squamous intraepithelial lesion (HSIL) of the cervix and to determine the impact of these miRNAs in the clinical course of cervical cancer development. Methods Between January 2020 and January 2022, a total of 35 patients with HSIL and 35 patients with cervical SCC and 30 healthy controls were enrolled in the study. Blood specimens from patients were collected and the relative miRNA expression levels of miR-409, miR-32, miR-454, miR-17, miR-520 and miR-373 in serum were analyzed by qRT-PCR. Receiver operating characteristic curve (ROC) was used to analyze the diagnostic potential of differentially expressed miRNAs. Results Compared with healthy controls, miR-409 was found to be significantly down-regulated, and miR-32, miR-454, and miR-17 were significantly up-regulated in HSIL and cervical SCC tissues. In addition, miR-409 was significantly downregulated, and miR-32, miR-454, and miR-17 were significantly upregulated in the cervical SCC group compared with the HSIL group. roC analysis showed that miR-409(AUC=0.972), miR-32(AUC=0.942), and miR-454(AUC=0.905), and miR-17(AUC=0.969) had high specificity and sensitivity in distinguishing the control and SCC groups. miR-409(AUC=0.921) and miR-17(AUC=0.851) had high specificity and sensitivity in distinguishing the HSIL and SCC groups. In addition, miR-32 and miR-454 were less sensitive in distinguishing HSIL group from SCC group. Conclusion In this study, four miRNAs (miR-409, miR-32, miR-454, miR-17) differentially expressed in the sera of normal controls, HSIL and SCC patients are identified, and these miRNAs show good sensitivity and specificity in distinguishing normal from SCC. Among them, miR-409 and miR-17 could also be used as potential markers to distinguish HSIL from SCC.

Key words： microRNA cervical cancer high-grade squamous intraepithelial lesion

收稿日期: 2022-11-01

中图分类号:

R737.33

基金资助:陕西省卫生健康委员会科研项目（20210186）

通讯作者: 闫琼琼,Email：kidney98902@163.com

引用本文:

赵文娇, 刘芳, 闫琼琼. MicroRNA表达在宫颈癌及癌前病变中的差异研究[J]. 湖南师范大学学报(医学版), 2023, 20(5): 84-89. ZHAO Wenjiao, LIU Fang, YAN Qiongqiong. Differential expression of MicroRNA in cervical cancer and precancerous lesions. HuNan ShiFan DaXue XueBao(YiXueBan), 2023, 20(5): 84-89.

链接本文:

http://yxb.hunnu.edu.cn/CN/ 或 http://yxb.hunnu.edu.cn/CN/Y2023/V20/I5/84

[1] 周斌, 谢福源, 苏学英, 等. 人乳头状瘤病毒与人类疱疹病毒重叠感染在宫颈上皮内瘤变及宫颈癌中的意义[J]. 实用医学杂志, 2020, 36(12): 1654-1658.
[2] 张韶凯, 罗喜平, 李志芳, 等. 人乳头瘤病毒分型检测在宫颈癌前病变和宫颈癌筛查中的应用价值[J]. 中华肿瘤杂志, 2020, 42(3): 252-256.
[3] 龙玉惠, 杨娇娥. 人乳头瘤病毒DNA分型检测宫颈液基薄层细胞学检查及阴道镜活检组织病理学检查在宫颈癌筛查中的应用价值[J]. 中国妇幼保健, 2021, 36(10): 2419-2421.
[4] Nahand JS, Vandchali NR, Darabi H, et al.Exosomal microRNAs: novel players in cervical cancer[J]. Epigenomics, 2020, 12(18): 1651-1660.
[5] 王玮玉, 沈影, 郭滢, 等. miRNAs表达异常在宫颈癌转移机制中的研究进展[J]. 中国细胞生物学学报, 2021, 43(7): 1495-1503.
[6] Andrés-León E, Rojas AM. miARma-Seq, a comprehensive pipeline for the simultaneous study and integration of miRNA and mRNA expression data[J]. Methods, 2019, 152: 31-40.
[7] Shukla V, Varghese VK, Kabekkodu SP, et al.Enumeration of deregulated miRNAs in liquid and tissue biopsies of cervical cancer[J]. Gynecol Oncol, 2019, 155(1): 135-143.
[8] Shen S, Zhang S, Liu P, et al.Potential role of microRNAs in the treatment and diagnosis of cervical cancer[J]. Cancer Genet, 2020, 248: 25-30.
[9] 陈翠云, 王梅云, 朱庆尧, 等. 循环miR-143水平在宫颈癌患者同步放化疗后肿瘤残留的早期预测[J]. 中华放射肿瘤学杂志, 2021, 30(9): 910-916.
[10] Yoshiko Y, Minamizaki T.Emerging roles of microRNAs as extracellular vesicle cargo secreted from osteoblasts[J]. J Oral Biosci, 2020, 62(3): 228-234.
[11] Babion I, Snoek BC, Novianti PW, et al.Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility study[J]. Clin Epigenetics, 2018, 10(1): 76.
[12] Shen S, Zhang S, Liu P, et al.Potential role of microRNAs in the treatment and diagnosis of cervical cancer[J]. Cancer Genet, 2020, 248: 25-30.
[13] Stoen MJ, Andersen S, Rakaee M, et al.High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients[J]. Sci Rep, 2021, 11(1): 13864.
[14] Wang Q, He Y, Kan W, et al.microRNA-32-5p targets KLF2 to promote gastric cancer by activating PI3K/AKT signaling pathway[J]. Am J Transl Res, 2019, 11(8): 4895-4908.
[15] Wu W, Chen Y, Ye S, et al.Transcription factor forkhead box K1 regulates miR-32 expression and enhances cell proliferation in colorectal cancer[J]. Oncol Lett, 2021, 21(5): 407.
[16] Wang F, Yan J.MicroRNA-454 is involved in regulating trophoblast cell proliferation, apoptosis, and invasion in preeclampsia by modulating the expression of ephrin receptor B4[J]. Biomed Pharmacother, 2018, 107: 746-753.
[17] Zuo J, Yu H, Xie P, et al.miR-454-3p exerts tumor-suppressive functions by down-regulation of NFATc2 in glioblastoma[J]. Gene, 2019, 710: 233-239.
[18] Li Y, Jiao Y, Fu Z, et al.High miR-454-3p expression predicts poor prognosis in hepatocellular carcinoma[J]. Cancer Manag Res, 2019, 11: 2795-2802.
[19] Feng J, Li K, Liu G, et al.Precision hyperthermia-induced miRNA-409-3p upregulation inhibits migration, invasion, and EMT of gastric cancer cells by targeting KLF17[J]. Biochem Biophys Res Commun, 2021, 549: 113-119.